AQR Capital Management
AGN

AQR Capital Management’s Allergan plc AGN Stock Holding History

AQR Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-409,718
Closed -$72.6M – 2205
2020
Q1 		$72.6M Sell
409,718
-22,396
-5% -$4.22M 0.12% 197
2019
Q4 		$82.6M Buy
432,114
+32,169
+8% +$5.8M 0.09% 271
2019
Q3 		$67.3M Buy
399,945
+163,070
+69% +$26.6M 0.08% 315
2019
Q2 		$39.7M Sell
236,875
-246,220
-51% -$34.1M 0.04% 437
2019
Q1 		$70.7M Sell
483,095
-213,504
-31% -$31M 0.08% 296
2018
Q4 		$93.1M Buy
696,599
+589,573
+551% +$96.6M 0.11% 210
2018
Q3 		$20.4M Buy
107,026
+86,292
+416% +$15.9M 0.02% 575
2018
Q2 		$3.46M Buy
20,734
+10,060
+94% +$1.62M ﹤0.01% 1180
2018
Q1 		$1.8M Buy
10,674
+2,866
+37% +$481K ﹤0.01% 1401
2017
Q4 		$1.28M Buy
7,808
+1,694
+28% +$304K ﹤0.01% 1575
2017
Q3 		$1.25M Sell
6,114
-1,658
-21% -$386K ﹤0.01% 1586
2017
Q2 		$1.89M Sell
7,772
-173
-2% -$40.7K ﹤0.01% 1407
2017
Q1 		$1.9M Buy
+7,945
New +$1.85M ﹤0.01% 1407
2016
Q4 		– Sell
-8,307
Closed -$1.91M – 2309
2016
Q3 		$1.91M Sell
8,307
-14,050
-63% -$3.43M ﹤0.01% 1437
2016
Q2 		$5.17M Sell
22,357
-385,186
-95% -$88.8M 0.01% 900
2016
Q1 		$109M Buy
407,543
+86,025
+27% +$24.6M 0.2% 150
2015
Q4 		$100M Buy
321,518
+242,188
+305% +$72.1M 0.18% 154
2015
Q3 		$21.6M Buy
79,330
+18,672
+31% +$5.74M 0.04% 464
2015
Q2 		$18.4M Sell
60,658
-38,638
-39% -$11.5M 0.04% 470
2015
Q1 		$29.6M Buy
99,296
+13,378
+16% +$3.81M 0.07% 319
2014
Q4 		$22.1M Buy
+85,918
New +$21.5M 0.05% 450
2013
Q4 		– Sell
-24,412
Closed -$3.52M – 2628
2013
Q3 		$3.52M Sell
24,412
-70,463
-74% -$9.39M 0.01% 975
2013
Q2 		$12M Buy
+94,875
New +$10.7M 0.04% 506

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AQR Capital Management's AGN Position: Q2 2020 in Review

AQR Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 409,718 shares — an estimated $72.6M sold.

AQR Capital Management first reported a position in AGN in Q2 2013 and held it in 23 quarters. The position peaked at $109M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AQR Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AQR Capital Management sold 409,718 Allergan plc shares in Q2 2020, an estimated $72.6M.
  • AQR Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 23 quarters.
  • AQR Capital Management's Allergan plc position peaked at $109M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AQR Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.